Are there any psychiatric drugs that can cause drug-induced lupus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Psychiatric Drugs That Can Cause Drug-Induced Lupus

Several psychiatric medications can cause drug-induced lupus, with chlorpromazine being the most well-documented among them. 1, 2

Psychiatric Medications Associated with Drug-Induced Lupus

  • Chlorpromazine (a phenothiazine antipsychotic) is clearly documented in FDA labeling to potentially cause "a systemic lupus erythematosus-like syndrome" 1
  • Clozapine (an atypical antipsychotic) has been reported to cause drug-induced lupus that resolved upon discontinuation and recurred with rechallenge 3
  • Other phenothiazines may carry similar risks as chlorpromazine 2
  • Carbamazepine and lithium carbonate have been identified as potentially lupus-inducing drugs 4

Clinical Presentation and Diagnosis

  • Drug-induced lupus typically presents with:
    • Arthralgia and myalgia 2
    • Pleurisy 2
    • Rashes and fever 2
    • Positive antinuclear antibodies in serum 2
  • Unlike idiopathic lupus, drug-induced lupus rarely causes serious manifestations such as:
    • Nephritis 2
    • Cerebral involvement 2
  • Diagnosis requires:
    • Temporal relationship between drug initiation and symptom onset
    • Exclusion of other causes
    • Resolution of symptoms after drug discontinuation 2
    • In some cases, symptom recurrence with drug rechallenge (as seen with clozapine) 3

Management of Drug-Induced Lupus

  • Discontinuation of the offending drug is the primary treatment 2
  • Symptoms typically resolve within a few weeks after stopping the medication 2
  • For neuropsychiatric manifestations of lupus:
    • Immunosuppressive therapy may be beneficial for inflammatory manifestations 5
    • Glucocorticoids combined with immunosuppressive agents (cyclophosphamide, followed by azathioprine maintenance) can be effective 5
    • In refractory cases, rituximab has shown significant improvement of psychiatric manifestations 5

Safer Alternatives for Patients with Lupus Requiring Psychiatric Treatment

  • For patients with existing lupus requiring psychiatric medication:
    • Avoid known lupus-inducing drugs like chlorpromazine, carbamazepine, and lithium 4
    • Consider newer atypical antipsychotics with fewer reported associations to lupus
    • Aripiprazole has been used successfully in adolescents with lupus-associated psychosis 6
    • SSRIs like paroxetine have been used as adjunctive therapy for neuropsychiatric lupus 7
    • In patients with Sjögren's syndrome (which can co-occur with lupus), avoid drugs with anticholinergic effects like phenothiazines and tricyclic antidepressants 4

Important Considerations

  • Psychiatric symptoms in patients with lupus may be due to:
    • Direct disease activity on the central nervous system 4
    • Side effects of medications used to treat lupus (e.g., corticosteroids) 4
    • Psychological reaction to chronic illness 4
  • When psychiatric symptoms develop in patients taking potentially lupus-inducing psychiatric medications, consider drug-induced lupus in the differential diagnosis 2
  • Early recognition is crucial as symptoms typically resolve with drug discontinuation 2

When prescribing psychiatric medications, especially antipsychotics like chlorpromazine, clinicians should maintain vigilance for symptoms suggestive of drug-induced lupus and promptly discontinue the medication if such symptoms develop.

References

Research

Drug-induced lupus.

Drug safety, 1995

Research

Clozapine-induced systemic lupus erythematosus.

The Annals of pharmacotherapy, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Improvement of Neuropsychiatric Lupus with Addition of SSRI Antidepressant/Antipsychotic Therapy.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.